OOIR: Observatory of International Research

Papers

(The H4-Index of Chest is 66. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019	470
The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic	463
Cross-Sectional Studies	439
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China	427
Antithrombotic Therapy for VTE Disease	349
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019	335
Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection	296
Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1	244
Hospital-Acquired Infections in Critically Ill Patients With COVID-19	219
Triage of Scarce Critical Care Resources in COVID-19 An Implementation Guide for Regional Allocation	210
Executive Summary	206
Persistent Exertional Intolerance After COVID-19	185
Characterization of Severe Asthma Worldwide	160
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma	156
Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19	152
Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019	140
Individualizing Risk Prediction for Positive Coronavirus Disease 2019 Testing	140
Fluid Response Evaluation in Sepsis Hypotension and Shock	139
Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019	135
Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza	134
Sample Size Estimation in Clinical Research	133
Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension	133
Real-World Effectiveness and the Characteristics of a “Super-Responder” to Mepolizumab in Severe Eosinophilic Asthma	132
The Use of Bronchoscopy During the Coronavirus Disease 2019 Pandemic	130
Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome	129

Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis	126
Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes	125
High-Flow, Noninvasive Ventilation and Awake (Nonintubation) Proning in Patients With Coronavirus Disease 2019 With Respiratory Failure	123
Transbronchial Cryobiopsy for the Diagnosis of Interstitial Lung Diseases	122
Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis	121
Robotic Bronchoscopy for Peripheral Pulmonary Lesions	120
Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU	112
Screening for Lung Cancer	111
Eosinophilic and Noneosinophilic Asthma	111
Disparities in Sleep Health and Potential Intervention Models	110
Medical Education During the COVID-19 Pandemic	108
Physical and Social Environment Relationship With Sleep Health and Disorders	106
The Coronavirus Disease 2019 Pandemic’s Effect on Critical Care Resources and Health-Care Providers	105
The Evolving Landscape of e-Cigarettes	104
Combined Treatment With Hydrocortisone, Vitamin C, and Thiamine for Sepsis and Septic Shock	104
Treatment of Community-Acquired Pneumonia in Immunocompromised Adults	101
Diagnosis and Evaluation of Hypersensitivity Pneumonitis	99
The Sleep Apnea-Specific Hypoxic Burden Predicts Incident Heart Failure	91
Pulmonary Thrombosis and Thromboembolism in COVID-19	91
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis	88
Sensitivity and Safety of Electromagnetic Navigation Bronchoscopy for Lung Cancer Diagnosis	88
Chest CT Imaging Signature of Coronavirus Disease 2019 Infection	86
Perioperative Management of Antithrombotic Therapy	85
Preliminary Findings on Control of Dispersion of Aerosols and Droplets During High-Velocity Nasal Insufflation Therapy Using a Simple Surgical Mask	83
Effect of Intermittent or Continuous Feed on Muscle Wasting in Critical Illness	83
Use of Tracheostomy During the COVID-19 Pandemic	80
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic	77
Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions	77
Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits	76
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism	74
Chest CT in COVID-19 at the ED: Validation of the COVID-19 Reporting and Data System (CO-RADS) and CT Severity Score	74
Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype	74
Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units	72
Mortality Risk Prediction in Amyopathic Dermatomyositis Associated With Interstitial Lung Disease	71
VTE in ICU Patients With COVID-19	71
Using Causal Diagrams to Improve the Design and Interpretation of Medical Research	71
Postmortem Lung Findings in a Patient With Asthma and Coronavirus Disease 2019	71
Lower vs Higher Fluid Volumes During Initial Management of Sepsis	70
Treatment of Mycobacterium abscessus Pulmonary Disease	68
Right Ventricular Dysfunction in Early Sepsis and Septic Shock	66
Feasibility of a 5G-Based Robot-Assisted Remote Ultrasound System for Cardiopulmonary Assessment of Patients With Coronavirus Disease 2019	66
Frequency, Risk Factors, Clinical Characteristics, and Outcomes of Spontaneous Pneumothorax in Patients With Coronavirus Disease 2019	66
Distribution, Risk Factors, and Temporal Trends for Lung Cancer Incidence and Mortality	66